Reactive Oxygen Species, SUMOylation, and Endothelial Inflammation
Figure 5
Outcome event mappings in 767 non-diabetic post-infarction patients from the THROMBO study demonstrating estimated outcome event rate as a function of HDL cholesterol and CRP levels (rank-transformed) for (a) carriers of the lower activity T allele (CT plus TT) and (b) homozygotes for the higher activity C allele.
